Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000289836 | SCV000340800 | uncertain significance | not provided | 2017-05-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082332 | SCV001002664 | benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002365318 | SCV002664049 | likely benign | Inborn genetic diseases | 2022-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001082332 | SCV001463166 | likely benign | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | 2020-06-07 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000289836 | SCV001927902 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000289836 | SCV001965409 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003957475 | SCV004767944 | likely benign | MTHFR-related disorder | 2019-07-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |